1. Home
  2. CWCO vs GOSS Comparison

CWCO vs GOSS Comparison

Compare CWCO & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CWCO
  • GOSS
  • Stock Information
  • Founded
  • CWCO 1973
  • GOSS 2015
  • Country
  • CWCO Cayman Islands
  • GOSS United States
  • Employees
  • CWCO N/A
  • GOSS N/A
  • Industry
  • CWCO Water Supply
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CWCO Utilities
  • GOSS Health Care
  • Exchange
  • CWCO Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • CWCO 515.6M
  • GOSS 586.6M
  • IPO Year
  • CWCO N/A
  • GOSS 2019
  • Fundamental
  • Price
  • CWCO $33.53
  • GOSS $3.29
  • Analyst Decision
  • CWCO Strong Buy
  • GOSS Strong Buy
  • Analyst Count
  • CWCO 1
  • GOSS 6
  • Target Price
  • CWCO $40.00
  • GOSS $8.60
  • AVG Volume (30 Days)
  • CWCO 85.2K
  • GOSS 4.3M
  • Earning Date
  • CWCO 11-13-2025
  • GOSS 11-06-2025
  • Dividend Yield
  • CWCO 1.69%
  • GOSS N/A
  • EPS Growth
  • CWCO N/A
  • GOSS N/A
  • EPS
  • CWCO 0.99
  • GOSS N/A
  • Revenue
  • CWCO $129,104,549.00
  • GOSS $40,237,000.00
  • Revenue This Year
  • CWCO $1.99
  • GOSS N/A
  • Revenue Next Year
  • CWCO $57.75
  • GOSS $30.65
  • P/E Ratio
  • CWCO $31.62
  • GOSS N/A
  • Revenue Growth
  • CWCO N/A
  • GOSS N/A
  • 52 Week Low
  • CWCO $22.69
  • GOSS $0.66
  • 52 Week High
  • CWCO $34.26
  • GOSS $3.60
  • Technical
  • Relative Strength Index (RSI)
  • CWCO 59.58
  • GOSS 70.27
  • Support Level
  • CWCO $32.74
  • GOSS $2.61
  • Resistance Level
  • CWCO $33.59
  • GOSS $3.60
  • Average True Range (ATR)
  • CWCO 0.75
  • GOSS 0.27
  • MACD
  • CWCO -0.11
  • GOSS 0.08
  • Stochastic Oscillator
  • CWCO 62.36
  • GOSS 74.69

About CWCO Consolidated Water Co. Ltd.

Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: